Literature DB >> 27037084

Varicella Zoster Virus Infection in Granulomatous Arteritis of the Aorta.

Don Gilden1, Teresa White2, Philip J Boyer3, Kristin M Galetta4, E Tessa Hedley-Whyte5, Meredith Frank6, Dawn Holmes6, Maria A Nagel2.   

Abstract

Granulomatous arteritis characterizes the pathology of giant cell arteritis, granulomatous aortitis, and intracerebral varicella zoster virus (VZV) vasculopathy. Because intracerebral VZV vasculopathy and giant cell arteritis are strongly associated with productive VZV infection in cerebral and temporal arteries, respectively, we evaluated human aortas for VZV antigen and VZV DNA. Using 3 different anti-VZV antibodies, we identified VZV antigen in 11 of 11 aortas with pathologically verified granulomatous arteritis, in 1 of 1 cases of nongranulomatous arteritis, and in 5 of 18 control aortas (28%) obtained at autopsy. The presence of VZV antigen in granulomatous aortitis was highly significant (P = .0001) as compared to control aortas, in which VZV antigen was never associated with pathology, indicating subclinical reactivation. VZV DNA was found in most aortas containing VZV antigen. The frequent clinical, radiological, and pathological aortic involvement in patients with giant cell arteritis correlates with the significant detection of VZV in granulomatous aortitis.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  VZV; granulomatous aortitis; granulomatous arteritis

Mesh:

Substances:

Year:  2016        PMID: 27037084      PMCID: PMC4878728          DOI: 10.1093/infdis/jiw101

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Recurrent dermatomal vesicular skin lesions: a clue to diagnosis of herpes simplex virus 2 meningitis.

Authors:  Nicole Gonzales; Kenneth L Tyler; Donald H Gilden
Journal:  Arch Neurol       Date:  2003-06

2.  Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Authors:  Leigh Zerboni; Raymond A Sobel; Michelle Lai; Richard Triglia; Megan Steain; Allison Abendroth; Ann Arvin
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography.

Authors:  Sergio Prieto-González; Pedro Arguis; Ana García-Martínez; Georgina Espígol-Frigolé; Itziar Tavera-Bahillo; Montserrat Butjosa; Marcelo Sánchez; José Hernández-Rodríguez; Josep M Grau; Maria C Cid
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

4.  Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia.

Authors:  Maria A Nagel; April Rempel; Jonathon Huntington; Forrest Kim; Alexander Choe; Don Gilden
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

5.  High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy.

Authors:  Esteban Cheng-Ching; Stephen Jones; Ferdinand K Hui; Shumei Man; Don Gilden; Adarsh Bhimraj; Ken Uchino
Journal:  J Neurol Sci       Date:  2015-02-16       Impact factor: 3.181

6.  Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Anna Heintzman; Alexander Choe; Philip J Boyer; Charles Grose; John E Carpenter; April Rempel; Nathan Bos; Balasubramaniyam Kandasamy; Kelly Lear-Kaul; Dawn B Holmes; Jeffrey L Bennett; Randall J Cohrs; Ravi Mahalingam; Naresh Mandava; Charles G Eberhart; Brian Bockelman; Robert J Poppiti; Madhura A Tamhankar; Franz Fogt; Malena Amato; Edward Wood; Vikram Durairaj; Steve Rasmussen; Vigdis Petursdottir; Lea Pollak; Sonia Mendlovic; Denis Chatelain; Kathy Keyvani; Wolfgang Brueck; Maria A Nagel
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

7.  Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients.

Authors:  Isabelle Marie; Alice Proux; Pierre Duhaut; Etienne Primard; Laure Lahaxe; Nicolas Girszyn; Jean-Pierre Louvel; Hervé Levesque
Journal:  Medicine (Baltimore)       Date:  2009-05       Impact factor: 1.889

8.  Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis.

Authors:  Mark P Burgoon; Randall J Cohrs; Jeffrey L Bennett; Sarah W Anderson; Alanna M Ritchie; Sabine Cepok; Bernhard Hemmer; Don Gilden; Gregory P Owens
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 9.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

10.  Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Authors:  Maria A Nagel; Teresa White; Nelly Khmeleva; April Rempel; Philip J Boyer; Jeffrey L Bennett; Andrea Haller; Kelly Lear-Kaul; Balasurbramaniyam Kandasmy; Malena Amato; Edward Wood; Vikram Durairaj; Franz Fogt; Madhura A Tamhankar; Hans E Grossniklaus; Robert J Poppiti; Brian Bockelman; Kathy Keyvani; Lea Pollak; Sonia Mendlovic; Mary Fowkes; Charles G Eberhart; Mathias Buttmann; Klaus V Toyka; Tobias Meyer-ter-Vehn; Vigdis Petursdottir; Don Gilden
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

View more
  16 in total

1.  Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung Fibroblasts.

Authors:  Dallas Jones; Anna Blackmon; C Preston Neff; Brent E Palmer; Don Gilden; Hussain Badani; Maria A Nagel
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 2.  Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Authors:  Maria A Nagel; Dallas Jones; Ann Wyborny
Journal:  J Neuroimmunol       Date:  2017-03-18       Impact factor: 3.478

Review 3.  Update on the management of giant cell arteritis.

Authors:  Janet Roberts; Alison Clifford
Journal:  Ther Adv Chronic Dis       Date:  2017-03-28       Impact factor: 5.091

Review 4.  Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Authors:  Rochella A Ostrowski; Sheela Metgud; Rodney Tehrani; Walter M Jay
Journal:  Neuroophthalmology       Date:  2019-07-02

Review 5.  Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Authors:  Anne A Gershon
Journal:  J Infect       Date:  2017-06       Impact factor: 6.072

6.  Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.

Authors:  Bryant R England; Ted R Mikuls; Fenglong Xie; Shuo Yang; Lang Chen; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

7.  Varicella Zoster Virus Alters Expression of Cell Adhesion Proteins in Human Perineurial Cells via Interleukin 6.

Authors:  Anna M Blackmon; Christina N Como; Andrew N Bubak; Teresa Mescher; Dallas Jones; Maria A Nagel
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

Review 8.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

Review 9.  Varicella zoster virus triggers the immunopathology of giant cell arteritis.

Authors:  Don Gilden; Maria A Nagel
Journal:  Curr Opin Rheumatol       Date:  2016-07       Impact factor: 5.006

10.  Varicella Zoster Virus Vasculopathy.

Authors:  Maria A Nagel; Andrew N Bubak
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.